Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation

Mostrar otras versiones (1)

Since the outbreak of COVID-19, many randomized controlled trials have been launched to test the efficacy of promising treatments. These trials will offer great promise for future treatment. However, a public health emergency calls for a balance between gathering sound evidence and granting therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong-tian, Cheng, Zhi-hao, Huang, Yong-ying, Lv, Xi-lin, Zhou, Yu-bo, Dong, Erdan, Liu, Jian-meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836536/
https://www.ncbi.nlm.nih.gov/pubmed/33521761
http://dx.doi.org/10.1016/j.xinn.2020.100028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836536/
https://www.ncbi.nlm.nih.gov/pubmed/33521761
http://dx.doi.org/10.1016/j.xinn.2020.100028

Ejemplares similares